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Volume 52, Number 3 Abstracts 805and symptomatic venous hypertension in the remaining 8 (40%). Tech-
nical success and resolution of the symptoms was achieved in all cases.
Locations CS placements are summarized in the Table. The mean
follow-up was 8.4 months, 3 cases (15%) of thrombosis occurred within
the first 3 months of stent placement requiring percutaneous thrombec-
tomy and percutaneous transluminal angioplasty (PTA). Three patients
required PTA for restenosis. The overall primary patency, assisted pri-
mary patency, and secondary patency were 66%, 94%, and 100% at 12
months, respectively.
Conclusion: Endovascular therapy with CS for CVOD is safe and
effective in hemodialysis patients. In the present series, we demonstrated
promising results with higher primary and secondary patency than angio-
plasty and bare-metal stents. CS placement should be considered in recalci-
trant lesions; however, further prospective and randomized studies are
necessary to determine whether CSs provide superior long-term results to
those achieved with PTA and bare-metal stents.
Location of covered stent placements
Location Subclavian vein Innominate vein Both veins
Right 1 5 5
Left 4 5 0
Placement Issues forHemodialysis CathetersWith Pre-existing Central
Lines and Catheters
Anil Hingorani, Daniel Jung, DO, Jerry Walkup, MS, Enrico Ascher, MD,
Natalie Marks, MD RVT, Alexsander Shiferson, DO, Kapil Gopal, MD, and
Theresa Jacob, PhD, Maimononides Medical Center, Brooklyn, NY
Background: It has been a widely accepted practice that a previously
placed pacemaker was a contraindication to placing a hemodialysis catheter
in the ipsilateral internal jugular vein. Fear of dislodging pacing wires,
tunneling close to the battery site, or causing venous obstruction has been a
concern for surgeons and interventionalists alike. We suggest that this
phobia is unfounded.
Methods: This is a retrospective review of 600 hemodialysis catheters
placed between 1999 and 2009. For each hemodialysis catheter that was
placed, the perioperative chest x-ray image was examined to evaluate for
pre-existing pacemakers and central catheters.
Results:We found 20 pacemakers and 19 central catheters on the same
side of the neck as the hemodialysis catheter that was placed in the ipsilateral
jugular vein. Subclavian central catheters were also left in place for these
procedures. The mean age of the patients was 73.6  12 years (median, 76
years). No patient exhibited malfunction or dislodgment of the central
catheter, the pacemaker, or automated implantable cardioverter-defibrillator
(AICD), or evidence of upper extremity venous obstruction based on signs
symptoms or duplex examinations.
Conclusions: Since the updated Disease Outcomes Quality Initia-
tive (DOQI) guidelines call for placement of the arteriovenous fistula
opposite the side of the hemodialysis catheter, pacemakers and AICDs,
we suggest the policy of placing the hemodialysis catheter in the ipsilat-
eral internal jugular vein is safe and spares the contralateral limb for
arteriovenous fistula creation.
Scientific Session II
Cervical Ribs—A Rare Entity but Clinically Significant
Julie A. Freischlag, MD, Kevin Chang, BS, Merve Gurkar, Thomas Reifsnyder,
MD, and Kylie Davis, Johns Hopkins Medical Institutions, Baltimore, Md
Objectives: Owing to their unique presentation, we reviewed our
operative experience in patients with large, clinically significant cervical ribs.
Methods: This was a retrospective review of a prospectively acquired
database.
Results: Between January 2006-December 2009, 19 patients (16
women)with cervical ribs underwent first rib resection and cervical rib resection.
Patients were an average age of 35 years (range, 16-51 years). Fourteen patients
had sustained arterial compromise as a result of their cervical ribs. Six patients
presented with arterial thrombosis, and two also had a venous thrombosis at
presentation. Five patients had undergone thrombolysis, one had received
angioplasty, and thrombectomy procedures had been attempted in two. Three
patients had visible and palpable pulsatile masses: one was painful, and one had
embolized. One patient had had a previous partial cervical rib resection. Three
patients underwent contralateral prophylactic operations due to the presence of
a cervical rib. The remaining five patients had neurogenic symptoms as the
indication for their operation. A transaxillary approach was used in 20 of the 22
operations to remove both the first rib and the cervical rib. The cervical rib was
fused to the first rib in 17 of 22 cases (77%).) A supraclavicular approach wasused in two patients to resect the axillosubclavian aneurysm and place an
interposition graft. All patients did well but required postoperative physical
therapy to gain strength and range of motion.
Conclusions: Significant cervical ribs are large and frequently are
fused to the first rib, which results in arterial compression or aneurysm
formation. Thrombosis and embolization can occur and causes arterial
ischemia. In these patients, both the cervical rib and the first rib must be
removed to relieve the arterial compromise and can be done safely
through a transaxillary approach. Only those patients with aneurysms
who need to have the artery resected and replaced should undergo a
supraclavicular approach.
Scientific Session III
Clinical Outcomes for Hostile Versus Favorable Aortic Neck Anatomy
in Endovascular Aortic Aneurysm Repair Using Modular Devices
Ali F. AbuRahma, MD, John E. Campbell, MD, Albeir Y. Mousa, MD,
Akhilesh Jain, MD, Patrick A. Stone, MD, Stephen M. Hass, MD, Aravinda
Nanjundappa, MD, L Scott Dean, MD, and Tammi Keiffer, RN, Robert C.
Byrd Health Sciences Center of W. Va. University, Charleston, WVa
Objective: This study analyzed the clinical implications of various
clinical features of proximal aortic neck anatomy in EVAR using modular
devices.
Methods: A total of 258 EVAR patients were divided into favorable
(FNA) or hostile neck anatomy (HNA). HNA was defined as having one or
more of the following features: length of10 mm, angle of60°, diameter of
28 mm, 50% circumferential thrombus, 50% calcified neck, and reverse
taper.
Results: Thirty-seven percent of patients had FNA and 63% had HNA.
TheHNA group included 46 angulated, 20 short, 19 dilated (28mm), 16
calcified, 93 thrombus lined, and 51 reverse tapered. The technical success
was 99%. The mean follow-up was 22 months (range, 1-78 months). The
perioperative complication and death rates for FNA were 3% and 0% vs 16%
and 3% for HNA (P  .0027). Operative blood loss, contrast volume, and
operative time were similar for both groups. Proximal type I early endoleaks
occurred in 9% of FNA vs 23% for HNA (P  .0068). Intraoperative
proximal aortic cuffs were used to seal endoleaks in 8% for FNA vs 22% for
HNA (P .0044). AAA expansion was noted in 6% for FNA vs 7% for HNA
(P  .8509). Rates of freedom from late type I endoleaks at 1, 2, 3, and 4
years were 97%, 97%, 97%, and 90% for FNA vs 89%, 89%, 89%, and 89% for
HNA (P  .1224; Fig 1). Graft patency rates at 1, 2, and 3 years were 99%,
99%, and 99% for FNA vs 97%, 92%, and 90% for HNA (P  .0925; Fig 2).
The rates for late interventions were 95%, 90%, 90%, and 90% for FNA vs
95%, 93%, 91%, and 85% for HNA (P  .6902; Fig. 3). The survival rates
were 93%, 84%, 76%, and 76% for FNA vs 88%, 82%, 74%, and 66% for HNA
(P  .2631; Fig. 4). Multivariate logistic regression analysis revealed that
reverse taper was a significant predictor for early type I endoleak (OR, 5.25,
P  .0001), reverse taper (OR, 5.95, P  .0001), and neck length (OR,
4.15, P  .0146) were predictors for aortic cuff use and circumferential
thrombus (OR, 2.44, P .0448) and neck angle (OR, 3.38, P .009) were
predictors for perioperative complications.
Conclusions: Patients with HNA can be treated with EVAR, but with
higher rates of early type I endoleak and intervention. However, the mid-
term outcomes were similar to FNA.
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Abdominal Aortic Aneurysms
Dieter O. Mayer, MD, FEBVS, FAPWCA, Mario Lachat, MD, Thomas
Pfammatter, Lukas Hechelhammer, MD, Frank J. Veith, MD, and Zoran
Rancic, MD, University Hospital of Zurich, Zurich, Switzerland and The
Cleveland Clinic, New York, NY
Objective: This study compared the late outcomes in patients who
survived 30 days after endovascular aneurysm repair (EVAR) and open repair
(OR) for ruptured abdominal aortic aneurysms (RAAA).Methods: Retrospective analysis was done of prospective data from all
RAAA presented to our service from 1998 to 2009. Of 252 RAAA, 13patients (5%) were treated nonoperatively (logistic issue, 2; poor prognosis,
10; death during CT scan, 1). Two patients had a nonrelated diagnosis
(gastrointestinal bleeding and type A dissection). A total of 122 patients
(49%) were treated by EVAR, and 115 (46%) with OR. The 30-day survival
for EVAR and OR was 85% (103 of 122) and 67% (78 of 115), respectively.
Mean follow-up was 43  34.3 months (range, 1-132 months). Loss to
follow-up for EVAR was 1%; for OR, 12%.
Results: The actual overall survival rate of all early EVAR and OR
survivors was 62% (64 of 103) and 45% (43 of 78), respectively. Cumulative
survival rates at 1, 3, and 5 years were 90%, 79%, and 69% for EVAR and 87%,
78% and 60% for OR, respectively.
Conclusions: This first series of long-term results after EVAR vs OR
for RAAA shows an at least equivalent cumulative survival rate of 69% vs 60%
at 5 years. Taking into account the short-term mortality reduction of EVAR
vs OR (14% vs 33%, relative risk reduction of 62%), EVAR for RAAA is
superior to open repair from the perspective of long-term as well as short-
term outcomes. EVAR should become the standard of care for all RAAA in
patients with suitable anatomy for EVAR.
Total Sac Retraction After Endovascular Aneurysm Repair: 4 Years’
Follow-Up, Correlation to Treatment Success and Predictive Factors.
Rabih Houbballah, MD, Marek Majewski, MD, and Jean-Pierre Becque-
min, MD, Massachusetts General Hospital, Boston, Mass, and Henri Mon-
dor Hospital, Creteil, France
Objectives: The principal aim of this study was to demonstrate that the
total sac retraction (TSR) was a predictive marker of durable success after
endovascular aneurysm repair (EVAR). If verified, surveillance of patients
with TSR may become unnecessary. We also tested patients and aneurysm-
related factors that may predict the occurrence of TSR.
Methods: A group of 371 patients treated by EVAR had a complete
clinical, CT scan, and duplex scan follow-up. Data were collected prospec-
tively and analyzed retrospectively. We assessed the difference between the
largest diameter of the aneurysm (D) and the diameter of the body of the
stent graft (D1) on each postoperative CT scan. TSR was defined as a
minimum of 75% reduction of this difference between the first and any of the
following CT scans. Treatment success was defined as survival free of
aneurysm-related death, type I or III endoleak, aneurysm expansion 5
mm, rupture, surgical conversion, migration, and graft occlusion. To assess
the predictive factors of TSR, we performed a multivariable analysis and a
logistic regression of the most significant variables.
Results:TSRwas observed in 24.8% (92 of 371) of the patients after an
average follow-up of 26  21 months. Follow-up in this group was a mean
duration of 50  26 months vs 45  25 months (P  NS). Survival was
significantly longer in TSR group (96  3 vs 93  3 months, P  .05). No
rupture, surgical or endovascular conversion was reported in the TSR group.
The frequency of type I (2.2% vs 15.4%, P  .001), type II (3.3% vs 29.4%,
P  106), type III endoleaks (1.1% vs 1.8%, P  NS), and secondary
interventions (3.3% vs 13.3%, P .05) was lower in TSR group. All type I
and III endoleaks were diagnosed and treated before TSR detection. Be-
cause TSR was detected, treatment success remained till last follow-up in 91
of 92 patients (98.9%). The independent predictive factors of TSRwere AAA
diameter55mm (OR, 3.91; 95%CI, 2.16-7.11), infrarenal aorta diameter
